Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for FLGT

Show aggregate FLGT holdings

News associated with FLGT

Federated Hermes Inc. Boosts Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 11.0% during the 1st quarter, HoldingsChannel reports. The fund owned 46,479 shares of the company’s stock after acquiring an additional 4,597 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $785,000 at the end […] - 2025-08-08 05:10:53

Fulgent Genetics (NASDAQ:FLGT) Upgraded to “Buy” at UBS Group

UBS Group upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a neutral rating to a buy rating in a report published on Tuesday, Marketbeat reports. The firm currently has $30.00 price objective on the stock, up from their prior price objective of $20.00. A number of other brokerages also recently issued reports on […] - 2025-08-06 04:38:58

Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its target price lowered by analysts at Piper Sandler from $23.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 1.06% from […] - 2025-08-06 02:52:55

Fulgent Genetics (NASDAQ:FLGT) Shares Down 3.4% After Analyst Downgrade

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report)’s share price dropped 3.4% on Monday after Piper Sandler lowered their price target on the stock from $23.00 to $21.00. Piper Sandler currently has a neutral rating on the stock. Fulgent Genetics traded as low as $17.92 and last traded at $17.90. Approximately 59,010 shares were traded […] - 2025-08-06 02:13:03

Fulgent Genetics (NASDAQ:FLGT) & Outset Medical (NASDAQ:OM) Head-To-Head Analysis

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership. Institutional and Insider Ownership 48.1% of Fulgent […] - 2025-07-23 04:07:07

Alps Advisors Inc. Sells 1,980 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)

Alps Advisors Inc. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 8.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,752 shares of the company’s stock after selling 1,980 shares during the period. Alps […] - 2025-07-16 05:23:11

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,654 shares of the company’s stock after […] - 2025-06-11 04:36:52

Two Sigma Investments LP Reduces Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Two Sigma Investments LP cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,082 shares of the company’s stock after selling 2,749 shares during the period. Two Sigma Investments LP’s […] - 2025-06-04 05:08:51

Squarepoint Ops LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Squarepoint Ops LLC boosted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 178.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,608 shares of the company’s stock after buying an additional 26,659 shares during the quarter. Squarepoint Ops LLC owned […] - 2025-06-03 05:04:50

State of Wyoming Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

State of Wyoming bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,109 shares of the company’s stock, valued at approximately $57,000. Several other hedge funds and other institutional investors […] - 2025-05-29 04:47:02

Quantinno Capital Management LP Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Quantinno Capital Management LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 13,079 shares of the company’s stock, valued at approximately $242,000. Several other large investors have also recently added to or reduced their stakes in the company. Millennium […] - 2025-05-27 04:56:53

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $987,000 Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 53,413 shares of the company’s stock after selling 2,800 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Fulgent Genetics were […] - 2025-05-26 04:43:01

Deutsche Bank AG Has $2.43 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Deutsche Bank AG raised its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 6.1% during the fourth quarter, Holdings Channel reports. The firm owned 131,430 shares of the company’s stock after purchasing an additional 7,532 shares during the period. Deutsche Bank AG’s holdings in Fulgent Genetics were worth $2,428,000 at the end of […] - 2025-05-22 05:36:54

Balyasny Asset Management L.P. Buys Shares of 26,313 Fulgent Genetics, Inc. (NASDAQ:FLGT)

Balyasny Asset Management L.P. bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 26,313 shares of the company’s stock, valued at approximately $486,000. Balyasny Asset Management L.P. owned 0.09% of […] - 2025-05-16 05:50:59

Comparing Fulgent Genetics (NASDAQ:FLGT) and Grail (NASDAQ:GRAL)

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Grail (NASDAQ:GRAL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Institutional & Insider Ownership 48.1% of Fulgent Genetics […] - 2025-05-12 02:54:58

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,045,815 shares of the company’s stock after selling 60,579 shares during the period. Dimensional Fund Advisors LP’s holdings in Fulgent Genetics were worth $19,316,000 as of its most recent […] - 2025-05-08 04:50:45

Barclays PLC Raises Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Barclays PLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 180,397 shares of the company’s stock after acquiring an additional 5,542 shares during the quarter. Barclays PLC’s holdings in Fulgent Genetics were worth $3,332,000 as of its most […] - 2025-04-29 05:18:59

Federated Hermes Inc. Buys 1,774 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)

Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 4.4% in the fourth quarter, HoldingsChannel reports. The fund owned 41,882 shares of the company’s stock after acquiring an additional 1,774 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $774,000 as of its […] - 2025-04-16 05:13:02

Piper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock Price

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its price target cut by equities researchers at Piper Sandler from $22.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective suggests a potential downside of 3.90% from the stock’s current price. Separately, […] - 2025-03-06 05:27:14

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund cut its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 12.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,609 shares of the company’s stock after selling 1,324 shares during the quarter. Illinois Municipal Retirement […] - 2025-03-05 08:01:50

SG Americas Securities LLC Cuts Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

SG Americas Securities LLC cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 28.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,518 shares of the company’s stock after selling 4,934 shares during the quarter. SG Americas Securities LLC’s holdings in Fulgent Genetics were worth $231,000 as of its most […] - 2025-02-07 06:25:42

Exchange Traded Concepts LLC Has $652,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Exchange Traded Concepts LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,324 shares of the company’s stock after acquiring an additional 1,689 shares […] - 2025-01-30 06:53:06

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc FLGT holdings

Date	Number of FLGT Shares Held	Base Market Value of FLGT Shares	Local Market Value of FLGT Shares	Change in FLGT Shares Held	Change in FLGT Base Value	Current Price per FLGT Share Held	Previous Price per FLGT Share Held
2025-09-26 (Friday)	40,265	USD 909,586	USD 909,586
2025-09-25 (Thursday)	40,265	USD 887,038	USD 887,038	0	USD -2,819	USD 22.03	USD 22.1
2025-09-24 (Wednesday)	40,265	USD 889,857	USD 889,857
2025-09-17 (Wednesday)	40,005	USD 881,310	USD 881,310	4,901	USD 111,128	USD 22.03	USD 21.94
2025-09-16 (Tuesday)	35,104	USD 770,182	USD 770,182
2025-09-12 (Friday)	34,874	USD 763,043	USD 763,043
2025-09-11 (Thursday)	34,874	USD 775,947	USD 775,947

Share Trades of FLGT by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-17	BUY	4,901			22.030*		18.66
2025-08-21	SELL	-94			21.395*		18.64 Profit of 1,752 on sale
2025-07-31	BUY	279			17.180*		18.64
2025-06-30	SELL	-186			19.880*		18.60 Profit of 3,460 on sale
2025-06-25	SELL	-93			19.570*		18.58 Profit of 1,728 on sale
2025-06-20	SELL	-186			19.530*		18.56 Profit of 3,453 on sale
2025-05-23	BUY	93			20.310*		18.18
2025-05-19	SELL	-93			21.220*		18.09 Profit of 1,683 on sale
2025-05-15	SELL	-282			20.040*		18.06 Profit of 5,092 on sale
2025-05-12	SELL	-94			20.120*		18.00 Profit of 1,692 on sale
2025-05-09	SELL	-94			19.700*		17.99 Profit of 1,691 on sale
2025-04-30	SELL	-94			17.350*		17.94 Profit of 1,686 on sale
2025-04-24	SELL	-188			19.040*		17.91 Profit of 3,368 on sale
2025-04-17	SELL	-94			17.860*		17.90 Profit of 1,682 on sale
2025-04-15	SELL	-282			19.080*		17.88 Profit of 5,042 on sale
2025-04-14	SELL	-282			18.950*		17.87 Profit of 5,039 on sale
2025-04-09	SELL	-376			17.660*		17.86 Profit of 6,717 on sale
2025-04-07	SELL	-658			17.100*		17.88 Profit of 11,766 on sale
2025-04-04	SELL	-940			16.860*		17.89 Profit of 16,820 on sale
2025-03-31	BUY	94			16.900*		17.92
2025-03-19	SELL	-188			16.870*		18.02 Profit of 3,388 on sale
2025-03-14	SELL	-564			17.240*		18.05 Profit of 10,182 on sale
2025-03-13	SELL	-188			16.980*		18.07 Profit of 3,397 on sale
2025-03-12	SELL	-3,196			17.480*		18.08 Profit of 57,773 on sale
2025-03-07	SELL	-188			18.590*		18.10 Profit of 3,402 on sale
2025-03-06	SELL	-282			17.900*		18.10 Profit of 5,104 on sale
2025-03-03	SELL	-94			15.280*		18.21 Profit of 1,712 on sale
2025-02-28	SELL	-564			15.450*		18.26 Profit of 10,296 on sale
2025-02-26	SELL	-94			16.240*		18.33 Profit of 1,723 on sale
2025-02-25	SELL	-282			16.290*		18.37 Profit of 5,180 on sale
2025-02-18	BUY	470			16.880*		18.51
2025-02-13	BUY	94			16.860*		18.61
2025-02-12	BUY	94			16.220*		18.66
2025-02-11	BUY	282			16.270*		18.71
2025-02-06	BUY	846			16.570*		18.87
2025-01-27	BUY	94			17.410*		19.31
2024-12-30	BUY	470			18.420*		19.50
2024-12-06	BUY	376			20.090*		19.41
2024-12-05	BUY	94			19.700*		19.40
2024-12-04	BUY	470			20.200*		19.37
2024-11-29	BUY	470			18.300*		19.40
2024-11-27	BUY	376			18.070*		19.52
2024-11-26	BUY	94			17.890*		19.59
2024-11-21	BUY	470			16.950*		19.89
2024-11-20	BUY	282			17.280*		20.03
2024-11-18	BUY	1,128			16.710*		20.43
2024-11-12	BUY	752			19.160*		20.51
2024-11-08	BUY	470			19.430*		20.59
2024-11-07	BUY	1,395			22.020*		20.48
2024-11-06	BUY	186			22.680*		20.30
2024-10-31	BUY	93			21.450*		19.61

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of FLGT

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer